Richard Pete Singer, MD, FAAN, FAHS

MEDICAL SPECIALTY:
Neurology

UNDERGRADUATE:
Alfred University  1968 BA
Alfred, New York

MEDICAL SCHOOL:State University School of Medicine  1977 MD
Buffalo, New York

INTERNSHIP:
State University School of Medicine  1977 – 1978
Buffalo, New York

RESIDENCY:
Albert Einstein College of Medicine  1978 – 1981
Department of Neurology

PRIVATE PRACTICE:
1981 to Present
Sunrise Medical Group (Formerly Neurological Associates)

BOARD CERTIFIED:
The American Board of Psychiatry and Neurology
1983  (cert #24940)

Diplomate – American Academy of Neurology  1992
Assurance and Utilization Review Physicians

FELLOWSHIP:
Fellow, American Academy of Neurology  1994
Fellow, American Headache Society  2014

STATE LICENSE:
Florida   #ME-0038509    (6/16/81)
New York #134813              (7/78)
California # G87959           (2/07)

HOSPITAL AFFILIATIONS:
Memorial Regional Hospital
Westside Regional Medical Center
Memorial West Hospital

MEMBERSHIP:
American Academy of Neurology
American Headache Society
International Headache Society
American Academy of Pharmaceutical Physicians

FACULTY:
Voluntary Clinical Associate Professor of Neurology
University of Miami School of Medicine

LANGUAGES:
Fluent English, Spanish and French

PROFESSIONAL EXPERIENCE:
February 1, 2015-Present
Investigator, Infinity Clinical Research, LLC.

1991-2000
Medical Director, Vivra Neurosciences,
Plantation, FL – Provided neurological services
to the healthcare industry

1985-February 1, 2015
President, Neurology Clinical Research, Inc.
Formerly Neurological Associates)

1981-Present:
Frequent Lecturer at Community Centers and
Hospitals at Miami, Florida

Frequent guest on local radio and TV talk shows
on Neurological Diseases.

CERTIFICATIONS:
GCP/HSP Training-NINDS, HSRP, GCP, HIPAA,
CSDD, UPDRS, SHEEHAN, COG TEST, MMSE, NPI, CSSR-S, MHIS, NPI
ELECTROPHYSIOLOGIC TESTING
INFORM RDC, ORACLE RDC, BIOCLINICA

PUBLICATIONS:
Levetiracetam for Partial Seizures, Results of a Double-blind, Randomized Clinical Trial
J.J. Cereghino, MD; V. Biton, MD; B. Abou-Khalil, MD;
F. Dreifuss, MD; L.J. Gauer, I. Leppik, MD; and the United States Levetiracetam Study Group
Neurology Vol. 55 No. 2 July 2000, Copyright 2000 by the American Academy of Neurology Published by Lippincott Williams & Wilkins

The Long-term Tolerability and Efficacy of Oral Zolmitriptan in Acute Treatment of Migraine.
The International 311C90 Long-term Study Group

Oral Almotriptan vs Oral Sumatriptan in the abortive treatment of Migraine.  Results of a Double-Blind, Randomized, Parallel-Group Optimum-Dose comparison.
Archives of Neurology June 2001, Vol. 58 No. 6.

Efficacy, Safety, and Tolerability of the Rotigotine Transdermal Patch in Patients with Early-stage, Idiopathic Parkinson’s Disease. A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Trial.

Randomized, placebo-controlled trial of Rofecoxib in the acute treatment of migraine.

A randomized trial of Frovatriptan for the intermittent prevention of menstrual migraine.

Pregablin for the treatment of Postherpetic Neuralgia.  A randomized, placebo-controlled trial.

Comparative Efficacy of Eletriptan 40mg Vs Sumatriptan 100 mg.

A Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Tolerability of a 4-mg Dose of Subcutaneous Sumatriptan for the Treatment of Acute Migraine Attacks in Adults.

Headache: The Journal of Head and Face Pain, Volume 45 , Issue 7

A New, Buffered Formulation of Diclofenac Potassium 50 mg. is Efficacious in the Treatment of Acute Migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT)

The Impact f Regularly Scheduled Neutralizing Antibody (NAb) Testing on Treatment Patterns Versus Usual Care in MS Patients Taking High-Dose Interferon (HD IFN)

PAIN: Journal of the IASP: Fibromyalgia Relapse Evaluation and Efficacy for Durability of Meaningful Relief (FREEDOM): A 6-Month, Double- Blind, Placebo-Controlled Trial with Pregabablin

Cephalgia: Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the international Migraine Pain Assessment Clinical Trial (IMPACT). R. Lipton, Brian Grosberg, R. P. Singer, Starr H. Pearlman, James V. Sorrentino, John N. Quiring and J. R. Saper

Headache: Twelve-Month Tolerabilityand Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System Timothy R. Smith, MD, RPh; Jerome Goldstein, Richard Singer, MD; Neil Pugach, MD; Stephen Silberstein, MD; Mark W. Pierce, MD, PhD

PRESENTATIONS:
Factors Influencing Patient Treatment and Satisfaction – Data from a Large International Study
R. Singer, R.F. Nelson, M.A.M. Bomhof, S. Evers
Presented at the 41st American Association for the Study of Headache, June 11-13, 1999

Factors Influencing Patient Treatment and Satisfaction – Data from a Large International Study
M.A.M. Bonhof, S. Evers, R. Singer, R.F. Nelson
Presented at the 9th International Headache Society Congress, June 22-26, 1999

Oral Zolmitriptan – Demonstrates High Efficacy in the Acute Treatment of True Menstrual Migraine
Presented at AstraZeneca meeting, October 20-21, 2003